Thomas Kim - Jun 15, 2022 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Role
Chief Executive Officer, Director
Signature
/s/ Blake Nielsen, as Attorney-in-Fact
Stock symbol
ENFN
Transactions as of
Jun 15, 2022
Transactions value $
$0
Form type
4
Date filed
6/17/2022, 09:46 PM
Previous filing
Oct 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +20.3K +2.4% $0.00 866K Jun 15, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENFN Stock Option (Right to Buy) Award $0 +32K $0.00 32K Jun 15, 2022 Class A Common Stock 32K $9.86 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consist of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan (the "Plan"). The restricted stock units will vest in full as follows: 6,762, 6,761 and 6,761 restricted stock units will vest on June 15, 2023, June 15, 2024 and June 15, 2025, respectively.
F2 These options were granted under the Plan and shall become exercisable as follows: 10,667, 10,667 and 10,666 on June 15, 2023, June 15, 2024 and June 15, 2025, respectively.